The value of randomised trials for efficacy in oncology: lessons from off-label prescribing



Rebecca McKibbin, PhD candidate, Yale University.


Other, please see description for details


Friday, 2 February, 2018 - 12:30 to 13:45

This paper investigates the role of efficacy evidence produced in randomised controlled trials (RCTs) on demand for cancer drugs. Rebecca McKibbin uses the unique setting of off-label prescribing, where it is possible to observe demand for a drug for a particular cancer both before and after a trial result is released.

Find flyers, registration, and complete event details at


Venue map

Updated:  24 April, 2017/Responsible Officer:  Dean, ANU College of Asia & the Pacific/Page Contact:  CAP Web Team